Journal
CANCER MEDICINE
Volume 11, Issue 5, Pages 1396-1412Publisher
WILEY
DOI: 10.1002/cam4.4525
Keywords
cancer biology; cancer risk factors; immunology; prognosis; target therapy
Categories
Funding
- Natural Science Foundation of Guangxi [2018GXNSFBA281141]
- Guangxi Educational Science Planning Key Project
- Guangxi Higher Education Undergraduate Teaching Reform Project [2020JGA14]
- Guangxi Zhuang Autonomous Region Health and Family Planning Commission Self-financed Scientific Research Project [Z20180979, Z20200928]
- College Student Innovation and Entrepreneurship Training Program Project [202010598052]
- Guangxi Medical University Education and Teaching Reform Project [2019XJGZ04]
- Guangxi Medical University Future Academic Stars Project [WLXSZX20081]
Ask authors/readers for more resources
This study comprehensively analyzes the expression, potential mechanisms, and clinical significance of BCAT1 in pan-cancer, revealing its differential expression in various cancers and its association with DNA methyltransferases expression, immune checkpoint inhibitors expression, microsatellite instability, and tumor mutational burden. The overexpression of BCAT1 is correlated with poor prognosis in cancer patients and has the potential to distinguish cancer tissues from normal tissues.
Background Although branched chain amino acid transaminase 1 (BCAT1) has been identified to play an essential role in multiple tumors, no studies on its role in pan-cancer have been consulted before. Methods The study comprehensively analyzes the expression, potential mechanisms, and clinical significance of BCAT1 in pan-cancer through utilizing 16,847 samples, providing novel clues for the treatment of cancers. A Kruskal-Wallis test and the Wilcoxon rank-sum and signed-rank tests were applied to investigate diverse BCAT1 expression between various groups (e.g., cancer tissues versus normal tissues). Spearman's rank correlation coefficient was used in all correlation analyses in the study. Cox analyses and Kaplan-Meier curves were utilized to identify the prognosis significance of BCAT1 expression in cancers. The significance of BCAT1 expression in differentiating cancer and non-cancer tissues was explored via the area under the receiver operating characteristic curves (AUC). Results The differential expression of BCAT1 was detected in various cancers (p < 0.05), which is relevant to some DNA methyltransferases expression. BCAT1 expression was associated with mismatch repair gene expression, immune checkpoint inhibitors expression, microsatellite instability, and tumor mutational burden in some cancers, indicating its potential in immunotherapy. BCAT1 expression showed prognosis significance and played a risk role in multiple cancers (hazard ratio > 0, p < 0.05). BCAT1 expression also demonstrated conspicuous ability to distinguish some cancers tissues from their normal tissues (AUC > 0.7), indicating its potential to detect cancers. Further analyses on head and neck squamous cell carcinoma certified upregulated BCAT1 expression at both mRNA and protein levels in this disease based on in-house tissue microarrays and multicenter datasets. Conclusions For the first time, the research comprehensively demonstrates the overexpression of BCAT1 in pan-cancer, which improves the understanding of the pathogenesis of BCAT1 in pan-cancer. Upregulated BCAT1 expression represented a poor prognosis for cancers patients, and it serves as a potential marker for cancer immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available